1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
682EA7145C727003C00258BBE00411885
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-effective-oncology-solid-tumors-medical-insights-management-team-structure-effectiveness-lessons-learned?opendocument
18
19opendocument
2018.97.14.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Effective Oncology (Solid Tumors) Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned

ID: 5853


Features:

21 Info Graphics

31 Data Graphics

430+ Metrics

15 Narratives


Pages/Slides: 64


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Effective Oncology (Solid Tumors) Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned”

STUDY OVERVIEW

Medical Affairs teams specializing in oncology — particularly those focused on solid tumors — must navigate an intricate web of clinical data, stakeholder engagement, and regulatory considerations to ensure that insights reach decision-makers effectively. Establishing well-structured frameworks is essential to ensuring clear, impactful insight dissemination.

Best Practices, LLC conducted this study to examine the frameworks that high-performing organizations use to streamline insight distribution in the solid tumors segment. This research delivers key benchmarks, explores lessons learned from industry leaders, and offers data-driven strategies to enhance the reach and impact of critical scientific insights in oncology.

Benchmark data is broken down into two different segments to provide deeper insights. Classifications reflect their approach and standing in oncology (solid tumors) medical insight generation: Insight Leaders (6 respondents) and Insight Majority (28 respondents).


KEY TOPICS

  • Structure of Oncology (Solid Tumors) Medical Insights and Dissemination Group
  • Disseminating Oncology (Solid Tumors) Insights: Tools, Activities and Effectiveness
  • Best Practices and Key Lessons Learned
  • Actionable Insights and Intelligence Gathering in Oncology (Solid Tumors)

KEY METRICS

  • Presence of a separate group that gathers and disseminates oncology (solid tumors) insights for Medical Affairs – Total benchmark class, Insight Leaders, and Insight Majority
  • Role of each of the groups within Medical Affairs for both gathering and disseminating oncology (solid tumors) insights – Total benchmark class, Insight Leaders, and Insight Majority
  • Roles of Medical Affairs sub-functions in gathering and disseminating oncology (solid tumors) insights – Insight Leaders and Insight Majority
  • Lead and support role of Medical Affairs groups in gathering and disseminating oncology (solid tumors) insights – Total benchmark class
  • Level of expertise of the person who is responsible for conveying oncology (solid tumors) medical insights to other functions – Total benchmark class, Insight Leaders, and Insight Majority
  • Strengths and weaknesses of oncology (solid tumors) insights gathering and dissemination group structure
  • Breakdown of intelligence deliverables types in oncology (solid tumors) – Total benchmark class, Insight Leaders, and Insight Majority
  • Tools used by Oncology (Solid Tumors) Medical teams to deliver insights to other functions – Total benchmark class, Insight Leaders, and Insight Majority
  • Effectiveness and importance of digital tools used by the Oncology (Solid Tumors) Medical Affairs team to gather, evaluate, and disseminate intelligence – Total benchmark class, Insight Leaders, and Insight Majority
  • Additional methods used by Oncology (Solid Tumors) Medical Affairs teams to gather intelligence (beyond KOL and HCP engagement)

SAMPLE KEY FINDINGS

  • Medical Affairs Insight Leadership: Most companies lean on Field teams (71%) and Medical Strategy (65%) to lead the Insight process. However, leading organizations have Medical Operations step in instead of Field Teams.

METHODOLOGY

Best Practices, LLC partnered with 34 executives from 23 top life sciences companies specializing in oncology (solid tumors) to uncover critical benchmarking insights. The study insights are mostly from directors and higher management executives, representing nearly 80% of the benchmark participants.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Communications; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical; Science


Companies Profiled:
Agios; Alkermes; ApotheCom; AstraZeneca; Bayer; Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Eisai; Eli Lilly and Company; Genentech; Ipsen; Janssen; Merck KGaA; Merck; Novartis; Roche; Sandoz; Sanofi Genzyme; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Teva Pharmaceuticals; Thermo Fisher Scientific

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.